Back to search

Article

The Economic Burden of Illness in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients from a Commercial and Medicaid Insurance Perspective

2021-03-22

Abstract excerpt

<h4>Background: </h4> Pediatric acute lymphoblastic leukemia (ALL) treatment regimens are lengthy, and there is limited data on the systemic and individual economic burden associated with treatment of ALL. <h4>Objective:</h4> This study aims to examine healthcare resource utilization (HCRU) and costs accrued during the first year of therapy among pediatric ALL patients, and to compare costs among those who are Com...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0ee7276-783a-58f8-8c4c-12b1fec44626
DOI
10.22541/au.161643935.57445827/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Economic Burden of Illness in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients from a Commercial and Medicaid Insurance PerspectiveDOI 10.22541/au.161643935.57445827/v1
Socioeconomic Disparities and Clinical Outcomes in Pediatric Acute Lymphoblastic Leukemia Across the Americas: An Integrative ReviewSemantic proximity
Costs Associated with Adverse Events from Remission Induction for Children with Acute Lymphoblastic Leukemia (ALL)Semantic proximity
Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS)Semantic proximity
Healthcare resource utilization and costs during first salvage therapy for relapsed or refractory acute myeloid leukemia in the United States.Semantic proximity
Real-World medical expenses of Hematopoietic Stem Cell Transplantation in Japan: A Nationwide Database StudySemantic proximity
Cost-Effectiveness Analysis of Dasatinib versus Imatinib in Pediatric Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia Patients in ChinaSemantic proximity
Cost of illness and economic burden of chronic lymphocytic leukemiaSemantic proximity
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.Semantic proximity
Healthcare Resource Utilization and Costs for Patients With Eosinophilic Granulomatosis With Polyangiitis in the United States: A Retrospective Analysis of Health Insurance Claims DataSemantic proximity
Evaluation of non-research and research industry payments to pediatric hematologist/oncologists in the United States between 2013 and 2021Semantic proximity
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databasesSemantic proximity
Real-world treatment patterns and healthcare resource use in patients with acute myeloid leukemia in Western Europe.Semantic proximity
Select a neighboring publication to make it the new centre.